Cytokinetics (CYTK) Return on Capital Employed Growth (1y) (2014 - 2026)
Cytokinetics (CYTK) Return on Capital Employed Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -1,490.00 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,629.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.41 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -310.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 3,193.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 399.00 |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | -83.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -83.00 |
| Mar 31, 2026 | -747.00 |
| Dec 31, 2025 | -658.00 |
| Sep 30, 2025 | -990.00 |
| Jun 30, 2025 | -151.00 |
| Mar 31, 2025 | 2,025.00 |
| Dec 31, 2024 | 2,972.00 |
| Sep 30, 2024 | 3,435.00 |
| Jun 30, 2024 | 1,506.00 |
| Mar 31, 2024 | -2,618.00 |
| Dec 31, 2023 | -3,925.00 |
| Sep 30, 2023 | -4,681.00 |
| Jun 30, 2023 | -3,862.00 |
| Mar 31, 2023 | -1,369.00 |
| Dec 31, 2022 | -931.00 |
| Sep 30, 2022 | 685.00 |
| Jun 30, 2022 | 84.00 |
| Mar 31, 2022 | -853.00 |
| Dec 31, 2021 | -456.00 |
| Mar 31, 2021 | 2,142.00 |